Clinical Trial Update: Rebeccamycin Analogue in Treating Patients With Advanced Liver and/or Biliary Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of a Rebeccamycin analogue for advanced liver and biliary cancers has been terminated. The study was sponsored by Case Comprehensive Ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Gallbladder Cancer
• Hepatocellular Carcinoma

Drugs mentioned

• Rebeccamycin analogue (rebeccamycin analogue)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Extrahepatic Bile Duct Cancer, Gallbladder Cancer | Phase 2 | Status: TERMINATED